Publicacions en què col·labora amb Carlos Juan Nicolau (7)

2011

  1. Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: Impact on the activity of imipenem, meropenem and doripenem

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 9, pp. 2022-2027

2010

  1. Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolates from chronically-infected cystic fibrosis patients

    Clinical Microbiology and Infection, Vol. 16, Núm. 9, pp. 1482-1487

  2. Corrigendum to " Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2" [Int. J. Antimicrob. Agents 34 (2009) 173-176]

    International Journal of Antimicrobial Agents

  3. Erratum: Fe de errores de «caracterizacin y epidemiologa molecular de betalactamasas de espectro extendido en Escherichia coli y Klebsiella pneumoniae en once hospitales espaoles (2004)» (Enferm Infecc Clin (2008) 26: 7 (404-410))

    Enfermedades Infecciosas y Microbiologia Clinica

2009

  1. Characterization of plasmids encoding blaESBL and surrounding genes in Spanish clinical isolates of Escherichia coli and Klebsiella pneumoniae

    Journal of Antimicrobial Chemotherapy, Vol. 63, Núm. 1, pp. 60-66

  2. Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2

    International Journal of Antimicrobial Agents, Vol. 34, Núm. 2, pp. 173-176

2008

  1. Caracterización y epidemiología molecular de betalactamasas de espectro extendido en Escherichia coli y Klebsiella pneumoniae en once hospitales españoles (2004)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 26, Núm. 7, pp. 404-410